Highlights

[BJASSET] YoY Quarter Result on 2010-12-31 [#2]

Stock [BJASSET]: BERJAYA ASSETS BHD
Announcement Date 22-Feb-2011
Admission Sponsor -
Sponsor -
Financial Year 30-Jun-2011
Quarter 31-Dec-2010  [#2]
Profit Trend QoQ -     -7.66%    YoY -     - %
Quarter Report


View:


Show?  YoY % Horiz. %

Quarter Result
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/10/09 31/10/08 CAGR
Revenue 105,651 83,281 84,918 93,405 0 72,224 75,041 6.84%
  YoY % 26.86% -1.93% -9.09% 0.00% 0.00% -3.75% -
  Horiz. % 140.79% 110.98% 113.16% 124.47% 0.00% 96.25% 100.00%
PBT 25,017 17,219 25,596 31,074 0 5,869 13,242 13.09%
  YoY % 45.29% -32.73% -17.63% 0.00% 0.00% -55.68% -
  Horiz. % 188.92% 130.03% 193.29% 234.66% 0.00% 44.32% 100.00%
Tax -6,924 -2,842 -1,557 -1,110 0 -1,357 -2,125 25.67%
  YoY % -143.63% -82.53% -40.27% 0.00% 0.00% 36.14% -
  Horiz. % 325.84% 133.74% 73.27% 52.24% -0.00% 63.86% 100.00%
NP 18,093 14,377 24,039 29,964 0 4,512 11,117 9.88%
  YoY % 25.85% -40.19% -19.77% 0.00% 0.00% -59.41% -
  Horiz. % 162.75% 129.32% 216.24% 269.53% 0.00% 40.59% 100.00%
NP to SH 16,250 12,605 22,851 28,187 0 3,469 9,875 10.11%
  YoY % 28.92% -44.84% -18.93% 0.00% 0.00% -64.87% -
  Horiz. % 164.56% 127.65% 231.40% 285.44% 0.00% 35.13% 100.00%
Tax Rate 27.68 % 16.51 % 6.08 % 3.57 % - % 23.12 % 16.05 % 11.12%
  YoY % 67.66% 171.55% 70.31% 0.00% 0.00% 44.05% -
  Horiz. % 172.46% 102.87% 37.88% 22.24% 0.00% 144.05% 100.00%
Total Cost 87,558 68,904 60,879 63,441 0 67,712 63,924 6.27%
  YoY % 27.07% 13.18% -4.04% 0.00% 0.00% 5.93% -
  Horiz. % 136.97% 107.79% 95.24% 99.24% 0.00% 105.93% 100.00%
Net Worth 2,081,335 1,929,792 1,828,080 1,604,319 - 1,253,316 1,231,601 10.68%
  YoY % 7.85% 5.56% 13.95% 0.00% 0.00% 1.76% -
  Horiz. % 168.99% 156.69% 148.43% 130.26% 0.00% 101.76% 100.00%
Dividend
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/10/09 31/10/08 CAGR
Div - - - - - - - -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Div Payout % - % - % - % - % - % - % - % -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Equity
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/10/09 31/10/08 CAGR
Net Worth 2,081,335 1,929,792 1,828,080 1,604,319 - 1,253,316 1,231,601 10.68%
  YoY % 7.85% 5.56% 13.95% 0.00% 0.00% 1.76% -
  Horiz. % 168.99% 156.69% 148.43% 130.26% 0.00% 101.76% 100.00%
NOSH 1,113,013 1,115,486 1,114,682 1,114,110 1,119,032 1,119,032 1,109,550 0.06%
  YoY % -0.22% 0.07% 0.05% -0.44% 0.00% 0.85% -
  Horiz. % 100.31% 100.53% 100.46% 100.41% 100.85% 100.85% 100.00%
Ratio Analysis
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/10/09 31/10/08 CAGR
NP Margin 17.13 % 17.26 % 28.31 % 32.08 % - % 6.25 % 14.81 % 2.85%
  YoY % -0.75% -39.03% -11.75% 0.00% 0.00% -57.80% -
  Horiz. % 115.67% 116.54% 191.15% 216.61% 0.00% 42.20% 100.00%
ROE 0.78 % 0.65 % 1.25 % 1.76 % - % 0.28 % 0.80 % -0.49%
  YoY % 20.00% -48.00% -28.98% 0.00% 0.00% -65.00% -
  Horiz. % 97.50% 81.25% 156.25% 220.00% 0.00% 35.00% 100.00%
Per Share
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/10/09 31/10/08 CAGR
RPS 9.49 7.47 7.62 8.38 - 6.45 6.76 6.78%
  YoY % 27.04% -1.97% -9.07% 0.00% 0.00% -4.59% -
  Horiz. % 140.38% 110.50% 112.72% 123.96% 0.00% 95.41% 100.00%
EPS 1.46 1.13 2.05 2.53 0.00 0.31 0.89 10.05%
  YoY % 29.20% -44.88% -18.97% 0.00% 0.00% -65.17% -
  Horiz. % 164.04% 126.97% 230.34% 284.27% 0.00% 34.83% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 1.8700 1.7300 1.6400 1.4400 - 1.1200 1.1100 10.62%
  YoY % 8.09% 5.49% 13.89% 0.00% 0.00% 0.90% -
  Horiz. % 168.47% 155.86% 147.75% 129.73% 0.00% 100.90% 100.00%
Adjusted Per Share Value based on latest NOSH - 2,558,270
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/10/09 31/10/08 CAGR
RPS 4.13 3.26 3.32 3.65 - 2.82 2.93 6.87%
  YoY % 26.69% -1.81% -9.04% 0.00% 0.00% -3.75% -
  Horiz. % 140.96% 111.26% 113.31% 124.57% 0.00% 96.25% 100.00%
EPS 0.64 0.49 0.89 1.10 0.00 0.14 0.39 10.05%
  YoY % 30.61% -44.94% -19.09% 0.00% 0.00% -64.10% -
  Horiz. % 164.10% 125.64% 228.21% 282.05% 0.00% 35.90% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.8136 0.7543 0.7146 0.6271 - 0.4899 0.4814 10.68%
  YoY % 7.86% 5.56% 13.95% 0.00% 0.00% 1.77% -
  Horiz. % 169.01% 156.69% 148.44% 130.27% 0.00% 101.77% 100.00%
Price Multiplier on Financial Quarter End Date
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/10/09 31/10/08 CAGR
Date 31/12/13 31/12/12 30/12/11 30/12/10 31/12/09 30/10/09 31/10/08 -
Price 0.9500 0.8900 0.8300 0.7800 0.4300 0.4600 0.2900 -
P/RPS 10.01 11.92 10.90 9.30 0.00 7.13 4.29 17.81%
  YoY % -16.02% 9.36% 17.20% 0.00% 0.00% 66.20% -
  Horiz. % 233.33% 277.86% 254.08% 216.78% 0.00% 166.20% 100.00%
P/EPS 65.07 78.76 40.49 30.83 0.00 148.39 32.58 14.32%
  YoY % -17.38% 94.52% 31.33% 0.00% 0.00% 355.46% -
  Horiz. % 199.72% 241.74% 124.28% 94.63% 0.00% 455.46% 100.00%
EY 1.54 1.27 2.47 3.24 0.00 0.67 3.07 -12.49%
  YoY % 21.26% -48.58% -23.77% 0.00% 0.00% -78.18% -
  Horiz. % 50.16% 41.37% 80.46% 105.54% 0.00% 21.82% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 0.51 0.51 0.51 0.54 0.00 0.41 0.26 13.92%
  YoY % 0.00% 0.00% -5.56% 0.00% 0.00% 57.69% -
  Horiz. % 196.15% 196.15% 196.15% 207.69% 0.00% 157.69% 100.00%
Price Multiplier on Announcement Date
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/10/09 31/10/08 CAGR
Date 19/02/14 07/02/13 15/02/12 22/02/11 - 04/12/09 03/12/08 -
Price 0.8500 0.8400 0.8700 0.8000 0.0000 0.4500 0.2800 -
P/RPS 8.95 11.25 11.42 9.54 0.00 6.97 4.14 16.08%
  YoY % -20.44% -1.49% 19.71% 0.00% 0.00% 68.36% -
  Horiz. % 216.18% 271.74% 275.85% 230.43% 0.00% 168.36% 100.00%
P/EPS 58.22 74.34 42.44 31.62 0.00 145.16 31.46 12.64%
  YoY % -21.68% 75.16% 34.22% 0.00% 0.00% 361.41% -
  Horiz. % 185.06% 236.30% 134.90% 100.51% 0.00% 461.41% 100.00%
EY 1.72 1.35 2.36 3.16 0.00 0.69 3.18 -11.21%
  YoY % 27.41% -42.80% -25.32% 0.00% 0.00% -78.30% -
  Horiz. % 54.09% 42.45% 74.21% 99.37% 0.00% 21.70% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 0.45 0.49 0.53 0.56 0.00 0.40 0.25 12.04%
  YoY % -8.16% -7.55% -5.36% 0.00% 0.00% 60.00% -
  Horiz. % 180.00% 196.00% 212.00% 224.00% 0.00% 160.00% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View candlestick stock charts with Technical indicators
MQ Affiliate
Be rewarded by being an MQ Affiliate
 
 

614  229  596  731 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 EFRAME 0.37+0.025 
 AT 0.09+0.01 
 KANGER 0.17-0.005 
 VC 0.055+0.005 
 MAHSING 1.00+0.02 
 VIVOCOM 0.0450.00 
 LUSTER 0.170.00 
 MRDIY 1.74-0.01 
 MLAB 0.020.00 
 SUPERMX 9.78+0.57 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Najib Facebook Post comments on GLOVES. What's the message? gloveharicut
2. Traders Brief 26 Oct 2020 - Key Support At 200D SMA To Prevent Further Slide HLBank Research Highlights
3. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
4. Traders Brief 27 Oct 2020 - Volatility Ahead Amid Internal and External Headwinds HLBank Research Highlights
5. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
6. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
7. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
8. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
PARTNERS & BROKERS